Liver Tumours in Children
Childhood Tumour Surgery › Liver tumours
Medically reviewed by Dr. Koushik Herle, MCh, DNB (Paediatric Surgery), Consultant Pediatric Surgeon and Pediatric Urologist, on 8 November 2026
Your toddler’s tummy has been looking rounder over the past few weeks. During a check-up, the doctor feels a firm lump under the right ribs. An ultrasound shows a mass in the liver, and a blood test called AFP (alpha-fetoprotein) is very high.
Hearing the words “liver tumour” is frightening, largely because most people think of adult liver cancer. However, liver tumours in children behave very differently from liver cancers in adults. Children do not usually have the long-standing liver damage (cirrhosis) behind adult liver cancer. Many childhood liver tumours respond well to chemotherapy, and the healthy part of a child’s liver can regrow to full size within weeks after part of it is removed.
The most common cancerous liver tumour in young children is hepatoblastoma, usually found before the age of 3. With internationally agreed children’s tumour protocols (such as SIOPEL and PHITT) that combine chemotherapy with complete surgical removal, most children with hepatoblastoma are cured.
Key points for parents
Important precaution. If a firm swelling is felt in the upper tummy, avoid pressing on it repeatedly and protect the child from rough play or falls, because a large liver tumour has a rich blood supply and can bleed. Go to the nearest emergency department if the child develops sudden severe tummy pain, pale lips, dizziness or a rapidly swelling tummy.
About two in three primary liver masses in children are malignant and one in three are benign. Age, scan features and the AFP level help tell them apart.
| Tumour | Typical age | Key features | Usual management |
|---|---|---|---|
| Hepatoblastoma | Under 3 years, mostly in the first 18 months | Malignant. The commonest childhood liver cancer. Linked to very low birth weight and extreme prematurity, and to conditions such as Beckwith-Wiedemann syndrome and familial adenomatous polyposis (FAP). AFP is raised in most. | Chemotherapy (usually cisplatin-based) to shrink the tumour, then complete surgical removal. Liver transplant for selected children. |
| Hepatocellular carcinoma (HCC) | Older children and teenagers | Malignant. Rarer in children. Includes the fibrolamellar type, and cases linked to chronic liver disease. | Complete surgical removal, with further treatment by protocol. |
| Undifferentiated embryonal sarcoma | About 6 to 10 years | Malignant. Often looks cystic on ultrasound. AFP is usually normal. | Multi-drug chemotherapy and complete surgical removal. |
| Infantile hepatic haemangioma | Newborns and young infants | Benign blood-vessel growth, the commonest benign liver mass in babies. Large or multiple lesions can strain the heart or lower thyroid hormone levels. | Observation or propranolol medicine. Surgery is rarely needed. |
| Mesenchymal hamartoma | Under 2 years | Benign developmental mass made of many fluid-filled cysts. Can grow large. | Surgical removal alone, with no chemotherapy. |
| Focal nodular hyperplasia and adenoma | Older children and teenagers | Benign solid nodules, often found by chance. | MRI monitoring. Surgery if the nodule grows, bleeds or causes pain. |
For liver, bile duct and gallbladder conditions that are not tumours, see liver, pancreas and spleen surgery in children, biliary atresia and choledochal cyst.
AFP is a protein made by the liver of the unborn baby. In hepatoblastoma, the tumour cells make large amounts of it, so it helps with diagnosis and with tracking treatment.
Surgical planning needs a clear map of how the tumour relates to the portal veins (bringing blood into the liver) and the hepatic veins and inferior vena cava (draining blood out). A chest CT checks the lungs, the commonest place for hepatoblastoma to spread.
Childhood liver tumours are staged internationally with the PRETEXT system (PRE-Treatment EXTent of disease), which divides the liver into four sections:
Radiologists add letters for involvement of the hepatic veins (V), portal vein (P), spread outside the liver (E), several nodules (F) and lung spread (M). The map is repeated after chemotherapy as the POST-TEXT stage.
In most children, an ultrasound-guided core needle biopsy under brief anaesthesia confirms the exact tumour type and its microscopic pattern, so that the oncology team can match the intensity of chemotherapy to the tumour.
Childhood liver tumours are managed by a multidisciplinary tumour board of the pediatric oncologist, pediatric surgeon, radiologist and pathologist. Before any operation, the PRETEXT scan at diagnosis and the POST-TEXT scan after chemotherapy are studied closely to confirm that the tumour can be removed completely while leaving a healthy part of the liver with its own blood inflow, blood outflow and bile drainage.
A few small, well-contained tumours (PRETEXT I or II, especially the pure fetal type) can sometimes be removed first. Most children receive several cycles of chemotherapy first, usually cisplatin-based, sometimes with doxorubicin for higher-risk groups. Chemotherapy is usually given through a chemoport or central line.
Complete surgical removal is essential for cure. After chemotherapy, the POST-TEXT map decides which section or sections of the liver must be removed.
In a minority of children, the tumour involves all four sections of the liver (POST-TEXT IV) even after chemotherapy, or wraps around the main vessels of both sides, so a partial resection cannot leave a working liver. These children may need removal of the whole liver and a liver transplant, from a living donor or a deceased donor.
Children who may need a transplant should be seen by a pediatric liver transplant team early, during the first cycles of chemotherapy. Planned transplant generally gives better results than a rescue transplant after an incomplete resection.
| Area | What helps |
|---|---|
| Hospital stay | After a major liver resection, children are watched closely in the pediatric ICU for the first day or two (clotting, sugar and liver tests). Many go home within about a week. |
| Finishing chemotherapy | Once the child has recovered from surgery, usually within a few weeks, the remaining planned cycles are completed. |
| Follow-up | AFP blood tests and abdominal ultrasound scans (with chest imaging) are repeated every few months at first, then less often over about five years. |
| Long-term checks | Hearing tests, kidney function, a heart scan if doxorubicin was used, and growth and school progress. |
Call the treating team the same day if the child has a fever of 38°C (100.4°F) or higher during chemotherapy or with a central line, persistent vomiting, yellow eyes or pale stools after surgery, or redness or swelling at the wound.
Liver resection is major surgery. Risks include bleeding, a temporary bile leak from the cut liver edge (usually managed with a drain), fluid in the tummy or right chest, wound infection and narrowing of a bile duct. Operating after chemotherapy has shrunk the tumour, in a centre with pediatric anaesthesia and ICU support, helps keep these risks low.
Operating on a child’s liver needs detailed knowledge of liver segment anatomy, fine instruments and close coordination with the pediatric oncologist and anaesthetist. Each step, from choosing the biopsy track so that it is removed with the tumour to timing surgery between chemotherapy cycles, is planned to protect both the chance of cure and the child’s long-term growth.
Yes, in most children. A child needs only a portion of healthy liver to remain, and the remaining liver grows back to the size the body needs over weeks to months, usually without long-term dietary restrictions.
The tumour cells make AFP. A steady fall during chemotherapy shows the tumour is responding, and a normal level after surgery that stays normal during follow-up is one of the most reliable signs of remission.
Most cases happen by chance and are not inherited. A small number are linked to Beckwith-Wiedemann syndrome or familial adenomatous polyposis. If your child has features of these conditions, or there is a family history of early bowel polyps, the oncology team may advise a genetic consultation.
Babies born extremely early with a very low birth weight (under 1,500 grams) have a higher chance of hepatoblastoma in early childhood, although the risk is still small. Awareness helps doctors look into any tummy swelling early.
No. Benign lesions such as infantile hepatic haemangioma are common in babies and often shrink with propranolol or observation alone, without an operation or cancer treatment.
Consult your pediatric surgeon early to understand your options.
Appointments: +91 8217553785
This page is educational information and is not a substitute for individual medical advice. Drafted with AI assistance and medically reviewed by Dr. Koushik Herle.